Royal Bank of Canada’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-163
| Closed | -$7K | – | 7434 |
|
|
2021
Q2 | $7K | Sell |
163
-177
| -52% | -$7.6K | ﹤0.01% | 6497 |
|
|
2021
Q1 | $16K | Buy |
340
+291
| +594% | +$13.7K | ﹤0.01% | 6081 |
|
|
2020
Q4 | $5K | Buy |
+49
| New | +$5K | ﹤0.01% | 6137 |
|
|
2020
Q3 | – | Sell |
-7
| Closed | -$1K | – | 6527 |
|
|
2020
Q2 | $1K | Sell |
7
-5
| -42% | -$714 | ﹤0.01% | 6056 |
|
|
2020
Q1 | $1K | Sell |
12
-197
| -94% | -$16.4K | ﹤0.01% | 6053 |
|
|
2019
Q4 | $23K | Buy |
209
+164
| +364% | +$18K | ﹤0.01% | 5209 |
|
|
2019
Q3 | $3K | Sell |
45
-54
| -55% | -$3.6K | ﹤0.01% | 5578 |
|
|
2019
Q2 | $8K | Buy |
+99
| New | +$8K | ﹤0.01% | 5265 |
|
|
2019
Q1 | – | Sell |
-3
| Closed | – | – | 6038 |
|
|
2018
Q4 | $0 | Sell |
3
-31
| -91% | – | ﹤0.01% | 6296 |
|
|
2018
Q3 | $4K | Sell |
34
-101
| -75% | -$11.9K | ﹤0.01% | 5757 |
|
|
2018
Q2 | $13K | Sell |
135
-186
| -58% | -$17.9K | ﹤0.01% | 5163 |
|
|
2018
Q1 | $40K | Buy |
321
+305
| +1,906% | +$38K | ﹤0.01% | 4556 |
|
|
2017
Q4 | $3K | Sell |
16
-142
| -90% | -$26.6K | ﹤0.01% | 5468 |
|
|
2017
Q3 | $49K | Buy |
158
+151
| +2,157% | +$46.8K | ﹤0.01% | 4696 |
|
|
2017
Q2 | $2K | Buy |
+7
| New | +$2K | ﹤0.01% | 5559 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6041 |
|
|
2015
Q4 | – | Sell |
-21
| Closed | -$2K | – | 6074 |
|
|
2015
Q3 | $2K | Sell |
21
-11
| -34% | -$1.05K | ﹤0.01% | 5801 |
|
|
2015
Q2 | $5K | Buy |
+32
| New | +$5K | ﹤0.01% | 5749 |
|